DUOX2 and colorectal carcinoma: As other studies have revealed the role of DUOX2 as a risk factor for Inflammatory Bowel Disease (IBD) and its implications for CRC progression, this lncRNA may contribute to CRC progression through regulating pathways involving immune response and chronic inflammation (60).